Sempermed Introduces StarMed Ultra Nitrile Exam Glove
Sempermed announces its new StarMed ® Ultra Nitrile examination glove. StarMed® Ultra Nitrile is the latest addition to the StarMed ® family (following the StarMed® Latex launch in April 2013). StarMed® Ultra Nitrile is manufactured with a second generation nitrile formula, providing an incomparable fit and feel without sacrificing the protection and peace of mind healthcare workers demand.
This unique formula reduces tackiness thus allowing for a quick and easy don. StarMed® Ultra Nitrile also carries the new Smart Dispense Technology, Single Glove Delivery System seal ensuring each box is packed to perfection and dispenses one glove at a time. This new technology is proven to eliminate unnecessary hassle and waste. Additionally, each box of StarMed® Ultra Nitrile contains 250 gloves (225 XL), providing even greater efficiencies to those in need of hand protection.
Due to the enhanced nitrile characteristics and innovative packaging, we expect StarMed® Ultra Nitrile to be a quick favorite, specifically to those involved in the medical and dental industries, says Brooke Rosenberg, director of marketing. Also by packaging in 250 per box we are helping our customers save money as well as staying in line with our Glove the Planet sustainability campaign."
The superior StarMed® Ultra Nitrile hand protection is available in sizes extra small through extra large. The product reorder numbers are SMTN251 (size x-small), SMTN252 (size small), SMTN253 (size medium), and SMTN254 (size large), and SMTN255 (size x-large).
Source: Sempermed USA, Inc.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
